People · Operator
Named in public records as an officer, director or promoter · active 2014–2020 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Inception 5, Inc. | — | Biotechnology | Series A | $5.0M | $180.8M | 2014 |
| Elgia Therapeutics, Inc. | — | Pharmaceuticals | Seed | $2.3M | $88.6M | 2020 |
Thomas Coll at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Thomas Coll on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| BRADLEY BOLZON | 1 | 10 |
| Petpiboon Prasit | 1 | 7 |
| Brian Hubbard | 1 | 4 |
| Alan Saltiel | 1 | 1 |
| Ariel Feldstein | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.